178 related articles for article (PubMed ID: 24396026)
1. Interferon regulatory factors in heart: stress response beyond inflammation.
Sun H; Wang Y
Hypertension; 2014 Apr; 63(4):663-4. PubMed ID: 24396026
[No Abstract] [Full Text] [Related]
2. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
3. Sensing heart stress.
Barki-Harrington L; Rockman HA
Nat Med; 2003 Jan; 9(1):19-20. PubMed ID: 12514714
[No Abstract] [Full Text] [Related]
4. Defining miRNA targets: balancing simplicity with complexity.
Freedman JE; Tanriverdi K
Circulation; 2013 May; 127(21):2075-7. PubMed ID: 23625958
[No Abstract] [Full Text] [Related]
5. Cell communications in the heart.
Tirziu D; Giordano FJ; Simons M
Circulation; 2010 Aug; 122(9):928-37. PubMed ID: 20805439
[No Abstract] [Full Text] [Related]
6. Interferon regulatory factor signalings in cardiometabolic diseases.
Zhang XJ; Zhang P; Li H
Hypertension; 2015 Aug; 66(2):222-47. PubMed ID: 26077571
[No Abstract] [Full Text] [Related]
7. RALT specifically halts maladaptive cardiac hypertrophy: a new kid on the block.
Bergmann MW; Zelarayan L
Hypertension; 2009 Mar; 53(3):454-5. PubMed ID: 19204178
[No Abstract] [Full Text] [Related]
8. Genetic factors in cardiac hypertrophy.
Dorn GW; Hahn HS
Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
[TBL] [Abstract][Full Text] [Related]
9. Cardiac hypertrophy: signal transduction, transcriptional adaptation, and altered growth control.
Wagner M; Mascareno E; Siddiqui MA
Ann N Y Acad Sci; 1999 Jun; 874():1-10. PubMed ID: 10415515
[TBL] [Abstract][Full Text] [Related]
10. Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection.
Zablocki D; Sadoshima J
Circ Res; 2013 Nov; 113(11):1192-5. PubMed ID: 24201113
[TBL] [Abstract][Full Text] [Related]
11. Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
Benito B; Nattel S
J Physiol; 2009 Nov; 587(Pt 21):5011-3. PubMed ID: 19880876
[No Abstract] [Full Text] [Related]
12. Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by beta(1)-integrin-microtubule signaling pathways.
Yutao X; Geru W; Xiaojun B; Tao G; Aiqun M
Eur J Heart Fail; 2006 Jan; 8(1):16-22. PubMed ID: 16198630
[TBL] [Abstract][Full Text] [Related]
13. Redox signaling in cardiac physiology and pathology.
Burgoyne JR; Mongue-Din H; Eaton P; Shah AM
Circ Res; 2012 Sep; 111(8):1091-106. PubMed ID: 23023511
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
[TBL] [Abstract][Full Text] [Related]
15. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy.
Sussman MA; McCulloch A; Borg TK
Circ Res; 2002 Nov; 91(10):888-98. PubMed ID: 12433833
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
[TBL] [Abstract][Full Text] [Related]
17. Response to "Detailed aspects of redox signaling in cardiac physiology and pathology".
Burgoyne JR; Din HM; Eaton P; Shah AM
Circ Res; 2013 Jan; 112(1):e2. PubMed ID: 23409289
[No Abstract] [Full Text] [Related]
18. Is CaMKII a link between inflammation and hypertrophy in heart?
Singh MV; Anderson ME
J Mol Med (Berl); 2011 Jun; 89(6):537-43. PubMed ID: 21279501
[TBL] [Abstract][Full Text] [Related]
19. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
McMullen JR; Jennings GL
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
[TBL] [Abstract][Full Text] [Related]
20. Tackling the EGFR in pathological tissue remodelling.
Chan HW; Smith NJ; Hannan RD; Thomas WG
Pulm Pharmacol Ther; 2006; 19(1):74-8. PubMed ID: 15979363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
